Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Transcription

Mammalian transcription factors in yeast: strangers in a familiar land

Key Points

  • Yeast has proven a valuable model system to understand eukaryotic transcription mechanisms. Extending the vale of the system even further, several investigators have attempted to express mammalian transcriptional activators or repressors directly in yeast.

  • Mammalian transcriptional activators have been tested in yeast either directly or as fusion proteins targeted to reporters by fusion to a yeast DNA-binding domain. Most mammalian activators retain function in yeast.

  • Yeast is an ideal system to carry out structure–function analysis. In many cases, activation domains of mammalian activators have been defined in yeast. Fine-structure analysis has also been carried out, particularly with p53. Several screens have identified point mutations in p53 that alter its activation potential.

  • When a mammalian activator is expressed in yeast and studied at a reporter where its endogenous DNA-binding sites have been inserted, structure–function analysis has been carried out both to map DNA-binding regions within the activator and to identify the ideal DNA-binding sequence.

  • Genetic approaches have been used in yeast to identify potential co-activators for mammalian transcription factors. This has been particularly useful in the case of nuclear hormone receptors, in which both the yeast SAGA–ADA and the SWI–SNF complex among other proteins have been identified as important for activator function.

  • Nuclear hormone receptors require binding to hormone for full activation potential. This hormone-dependent stimulation can be recapitulated in yeast, which has led investigators to map hormone-binding domains and study the efficacy of different ligands. Furthermore, regulation of activator function in yeast by phosphorylation and binding to other mammalian regulatory proteins has been studied.

  • Transcriptional repression by mammalian proteins has also been shown in yeast, although to a lesser extent than with activators. Both Mad–Max and pRB recruit histone deacetylase activity in yeast much as they do in mammalian cells.

Abstract

Many transcription factors in human cells have functional orthologues in yeast, and a common experimental theme has been to define the function of the yeast protein and then test whether the mammalian version behaves similarly. Although, at first glance, this approach does not seem feasible for factors that do not have yeast counterparts, mammalian transcriptional activators or repressors can be expressed directly in yeast. Often, the mammalian factor retains function in yeast, and this allows investigators to exploit the experimental tractability of yeast to ask a diverse set of questions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Identifying transcriptional activators.
Figure 2: Structure–function analysis of activators.
Figure 3: Studying protein–DNA interactions.
Figure 4: Mechanisms of activation.
Figure 5: Regulation of transcriptional activators.
Figure 6: Transcriptional repressors.

Similar content being viewed by others

References

  1. Brownell, J. et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acteylation to gene expression. Cell 84, 843–851 (1996).

    Article  CAS  PubMed  Google Scholar 

  2. Taunton, J., Hassig, C. A. & Schreiber, S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408–411 (1996).

    Article  CAS  PubMed  Google Scholar 

  3. Chen, D. et al. Regulation of transcription by a protein methyltransferase. Science 284, 2174–2177 (1999).

    Article  CAS  PubMed  Google Scholar 

  4. Strahl, B. D., Ohba, R., Cook, R. G. & Allis, C. D. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl Acad. Sci. USA 96, 14967–14972 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593–599 (2000).

    Article  CAS  PubMed  Google Scholar 

  6. Sassone-Corsi, P et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285, 886–891 (1999).

    Article  CAS  PubMed  Google Scholar 

  7. Thomson, S. et al. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 18, 4779–4793 (1999).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Bestor, T., Laudano, A., Mattaliano, R. & Ingram, V. Cloning and sequencing of a cDNA methyltransferase of mouse cells. The carboxy-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203, 971–983 (1988).

    Article  CAS  PubMed  Google Scholar 

  9. Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219–220 (1998).

    Article  CAS  PubMed  Google Scholar 

  10. Kawasaki, H. et al. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405, 195–200 (2000).

    Article  CAS  PubMed  Google Scholar 

  11. Laurent, B. C., Treich, I. & Carlson, M. The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation. Genes Dev. 7, 583–591 (1993).

    Article  CAS  PubMed  Google Scholar 

  12. Cote, J., Quinn, J., Workman, J. L. & Peterson, C. L. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 265, 53–60 (1994).

    Article  CAS  PubMed  Google Scholar 

  13. Kwon, H., Imbalzano, A. N., Khavari, P. A., Kingston, R. E. & Green, M. R. Nucleosome disruption and enhancement of activator binding by a human SWI/SNF complex. Nature 370, 477–481 (1994).

    Article  CAS  PubMed  Google Scholar 

  14. Näär, A. M., Lemon, B. D. & Tjian, R. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70, 475–501 (2001).

    Article  PubMed  Google Scholar 

  15. Strubin, M. & Struhl, K. Yeast and human TFIID with altered DNA-binding specificity for TATA elements. Cell 68, 721–730 (1992).

    Article  CAS  PubMed  Google Scholar 

  16. Keaveney, M., Berkenstam, A., Feigenbutz, M., Vriend, G. & Stunnenberg, H. G. Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells. Nature 365, 562–566 (1993).

    Article  CAS  PubMed  Google Scholar 

  17. Cormack, B. P., Strubin, M., Stargell, L. A. & Struhl, K. Conserved and nonconserved functions of the yeast and human TATA-binding proteins. Genes Dev. 8, 1335–1343 (1994).

    Article  CAS  PubMed  Google Scholar 

  18. Sweetser, D., Nonet, M. & Young, R. Prokaryotic and eukaryotic RNA polymerases have homologous core subunits. Proc. Natl Acad. Sci. USA 84, 1192–1196 (1987).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Dynlacht, B. D., Hoey, T. & Tjian, R. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 66, 563–576 (1991).

    Article  CAS  PubMed  Google Scholar 

  20. Candau, R. et al. Identification of human proteins functionally conserved with the yeast putative adaptors ADA2 and GCN5. Mol. Cell. Biol. 16, 593–602 (1996).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H. & Nakatani, Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319–324 (1996).

    Article  CAS  PubMed  Google Scholar 

  22. Khavari, P. A., Peterson, C. L., Tamkun, J. W., Mendel, D. B. & Crabtree, G. R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366, 170–174 (1993).

    Article  CAS  PubMed  Google Scholar 

  23. Brent, R. & Ptashne, M. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. Cell 43, 729–736 (1985).

    Article  CAS  PubMed  Google Scholar 

  24. Hope, I. A. & Struhl, K. Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast. Cell 46, 885–894 (1986).

    Article  CAS  PubMed  Google Scholar 

  25. Fields, S. & Song, O. A novel genetic system to detect protein–protein interactions. Nature 340, 245–246 (1989).

    Article  CAS  PubMed  Google Scholar 

  26. Struhl, K. The DNA-binding domains of the jun oncoprotein and the yeast GCN4 transcriptional activator protein are functionally homologous. Cell 50, 841–846 (1987).

    Article  CAS  PubMed  Google Scholar 

  27. Bohmann, D. et al. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238, 1386–1392 (1987).

    Article  CAS  PubMed  Google Scholar 

  28. Kakidani, H. & Ptashne, M. GAL4 activates gene expression in mammalian cells. Cell 52, 161–167 (1988).

    Article  CAS  PubMed  Google Scholar 

  29. Webster, N., Jin, J. R., Green, S., Hollis, M. & Chambon, P. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52, 169–178 (1988).References 28 and 29 were the first reports to show that yeast activators can function in mammalian cells.

    Article  CAS  PubMed  Google Scholar 

  30. Struhl, K. The JUN oncoprotein, a vertebrate transcription factor, activates transcription in yeast. Nature 332, 649–650 (1988).

    Article  CAS  PubMed  Google Scholar 

  31. Lech, K., Anderson, K. & Brent, R. DNA-bound Fos proteins activate transcription in yeast. Cell 52, 179–184 (1988).References 30 and 31 show that mammalian activators can function in yeast.

    Article  CAS  PubMed  Google Scholar 

  32. McEwan, I. J. Bakers yeast rises to the challenge: reconstitution of mammalian steroid receptor signaling in S. cerevisiae. Trends Genet. 17, 239–243 (2001).

    Article  CAS  PubMed  Google Scholar 

  33. Metzger, D., White, J. H. & Chambon, P. The human oestrogen receptor functions in yeast. Nature 334, 31–36 (1988).

    Article  CAS  PubMed  Google Scholar 

  34. Schena, M. & Yamamoto, K. R. Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science 241, 965–967 (1988).References 33 and 34 were the first to show that nuclear steroid hormone receptors activate transcription in yeast.

    Article  CAS  PubMed  Google Scholar 

  35. Kunzler, M., Braus, G. H., Georgiev, O., Seipel, K. & Schaffner, W. Functional differences between mammalian transcription activation domains at the yeast GAL1 promoter. EMBO J. 13, 641–645 (1994).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Kim, T. K. & Roeder, R. G. Transcriptional activation in yeast by the proline-rich activation domain of human CTF1. J. Biol. Chem. 268, 20866–20869 (1993).

    CAS  PubMed  Google Scholar 

  37. Ponticelli, A. S., Pardee, T. S. & Struhl, K. The glutamine-rich activation domains of human Sp1 do not stimulate transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 983–988 (1995).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Prakash, K., Fang, X. D., Engelberg, D., Behal, A. & Parker, C. S. dOct2, a Drosophila Oct transcription factor that functions in yeast. Proc. Natl Acad. Sci. USA 89, 7080–7084 (1992).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Xiao, H. & Jeang, K. T. Glutamine-rich domains activate transcription in yeast Saccharomyces cerevisiae. J. Biol. Chem. 273, 22873–22876 (1998).

    Article  CAS  PubMed  Google Scholar 

  40. Escher, D., Bodmer-Glavas, M., Barberis, S. & Schaffner, W. Conservation of glutamine-rich transactivation function between yeast and humans. Mol. Cell. Biol. 20, 2774–2782 (2000).Interesting study that shows that re-establishing a mammalian promoter structure in yeast might be important for a corresponding mammalian activator to function in yeast.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Giese, K., Cox, J. & Grosschedl, R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69, 185–195 (1992).

    Article  CAS  PubMed  Google Scholar 

  42. Paull, T. T., Haykinson, M. J. & Johnson, R. C. The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures. Genes Dev. 7, 1521–1534 (1992).

    Article  Google Scholar 

  43. Landsman, D. & Bustin, M. Assessment of the transcriptional activation potential of the HMG chromosomal proteins. Mol. Cell. Biol. 11, 4483–4489 (1991).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Ma, J. & Ptashne, M. A new class of yeast transcriptional activators. Cell 51, 113–119 (1987).

    Article  CAS  PubMed  Google Scholar 

  45. Morin, P. J. & Gilmore, T. D. The C terminus of the NF-κB p50 precursor and an IκB isoform contain transcription activation domains. Nucleic Acids Res. 20, 2453–2458 (1992).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Pham, T. A., Hwung, Y.-P., Santiso-Mere, D., McDonnell, D. P. & O' Malley, B. W. Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol. Endocrinol. 6, 1043–1050 (1992).

    CAS  PubMed  Google Scholar 

  47. Chen, R. H. & Lipsick, J. S. Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 4423–4431 (1993).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Seneca, S. et al. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast. Oncogene 8, 2335–2342 (1993).

    CAS  PubMed  Google Scholar 

  49. Xie, K., Lambie, E. J. & Snyder, M. Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol. 13, 6170–6179 (1993).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Monaci, P. et al. A complex interplay of positive and negative elements is responsible for the different transcriptional activity of liver NF1 variants. Mol. Biol. Rep. 21, 147–158 (1995).

    Article  CAS  PubMed  Google Scholar 

  51. Yamaguchi, Y. & Kuo, M. T. Functional analysis of aryl hydrocarbon receptor nuclear translocator interactions with aryl hydrocarbon receptor in the yeast two-hybrid system. Biochem. Pharmacol. 50, 1295–1302 (1995).

    Article  CAS  PubMed  Google Scholar 

  52. Monteiro, A. N. A., August, A. & Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl Acad. Sci. USA 93, 13595–13599 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Rowlands, J. C., McEwan, I. J. & Gustafsson, J.-Å. Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Mol. Pharmocol. 50, 538–548 (1996).

    CAS  Google Scholar 

  54. Hecht, A., Letterst, C. M., Huber, O. & Kemier, R. Functional characterization of multiple transactivating elements in β-catenin, some of which interact with the TATA-binding protein in vitro. J. Biol. Chem. 274, 18017–18025 (1999).

    Article  CAS  PubMed  Google Scholar 

  55. Almlöf, T., Gustafsson, J.-Å. & Wright, A. P. H. Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol. Cell. Biol. 17, 934–945 (1997).

    Article  PubMed Central  PubMed  Google Scholar 

  56. Fields, S. & Jang, S. K. Presence of a potent transcription activating sequence in the p53 protein. Science 249, 1046–1049 (1990).

    Article  CAS  PubMed  Google Scholar 

  57. Shimada, A. et al. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences. Cancer Res. 59, 2781–2789 (1999).

    CAS  PubMed  Google Scholar 

  58. Nozaki, M. et al. p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade. Brain Pathol. 11, 296–305 (2001).

    Article  CAS  PubMed  Google Scholar 

  59. Scharer, E. & Iggo, R. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res. 20, 1539–1545 (1992).This paper shows that tumour-derived p53 mutants fail to activate transcription in yeast.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  60. Di Como, C. J. & Prives, C. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene 16, 2527–2539 (1998).

    Article  CAS  PubMed  Google Scholar 

  61. Flaman, J. M. et al. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast. Oncogene 16, 1369–1372 (1998).

    Article  CAS  PubMed  Google Scholar 

  62. Campomenosi, P. et al. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Oncogene 20, 3573–3579 (2001).

    Article  CAS  PubMed  Google Scholar 

  63. Epstein, C. B. et al. p53 mutations isolated in yeast based on loss of transcription factor activity: similarities and differences from p53 mutations detected in human tumors. Oncogene 16, 2115–2122 (1998).

    Article  CAS  PubMed  Google Scholar 

  64. Ishioka, C. et al. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nature Genet. 5, 124–129 (1993).

    Article  CAS  PubMed  Google Scholar 

  65. Meinhold-Heerlein, I. et al. Evaluation of methods to detect p53 mutations in ovarian cancer. Oncology 60, 176–188 (2001).

    Article  CAS  PubMed  Google Scholar 

  66. Inga, A. et al. Simple identification of dominant p53 mutants by a yeast functional assay. Carcinogenesis 18, 2019–2021 (1997).

    Article  CAS  PubMed  Google Scholar 

  67. Inga, A., Monti, P., Fronza, G., Darden, T. & Resnick, M. A. p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay. Oncogene 20, 501–513 (2001).

    Article  CAS  PubMed  Google Scholar 

  68. Brachmann, R. K., Yu, K., Eby, Y., Pavletich, N. P. & Boeke, J. D. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations. EMBO J. 17, 1847–1859 (1998).Isolation of second-site intragenic mutations which restore transactivation to tumour-derived TP53 mutants — a possible framework for small-molecule design.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  69. Maurici, D. et al. Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay. Oncogene 20, 3533–3540 (2001).

    Article  CAS  PubMed  Google Scholar 

  70. Nigro, J. M., Sikorski, R., Reed, S. I. & Vogelstein, B. Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol. Cell. Biol. 12, 1357–1365 (1992).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  71. Inga, A. & Resnick, M. A. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants. Oncogene 20, 3409–3419 (2001).

    Article  CAS  PubMed  Google Scholar 

  72. Olson, D. P. & Koenig, R. J. 5′-flanking sequences in thyroid hormone response element half-sites determine the requirement of retinoid X receptor for receptor-mediated gene expression. J. Biol. Chem. 272, 9907–9914 (1997).

    Article  CAS  PubMed  Google Scholar 

  73. Brent, G. A. et al. Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element. Mol. Endocrinol. 3, 1996–2004 (1989).

    Article  CAS  PubMed  Google Scholar 

  74. Katz, R. W. & Koenig, R. J. Nonbiased identification of DNA sequences that bind thyroid hormone receptor α1 with high affinity. J. Biol. Chem. 268, 19392–19397 (1993).

    CAS  PubMed  Google Scholar 

  75. Berge, T., Bergholtz, S. L., Andersson, K. B. & Gabrielson, O. S. A novel system for in vivo selection of recognition sequences: defining an optimal c-Myb-responsive element. Nucleic Acids Res. 29, E99 (2001).This report describes a system to identify optimal mammalian transcription-factor-binding sites in yeast.

  76. Henry, K. W., Carey, B., Howard, W. R., Hoefner, D. & Noonan, D. J. Use of Saccharomyces cerevisiae in the identification of novel transcription factor DNA binding specificities. Yeast 18, 445–454 (2001).

    Article  CAS  PubMed  Google Scholar 

  77. Yoshinaga, S. K., Peterson, C. L., Herskowitz, I. & Yamamoto, K. R. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258, 1598–1604 (1992).This study shows that glucocorticoid-receptor-dependent activation requires the SWI–SNF complex.

    Article  CAS  PubMed  Google Scholar 

  78. Cairns, B. R., Levinson, R. S., Yamamoto, K. R. & Kornberg, R. D. Essential role of Swp73p in the function of yeast Swi/Snf complex. Genes Dev. 10, 2131–2144 (1996).

    Article  CAS  PubMed  Google Scholar 

  79. Gilbert, D. M., Losson, R. & Chambon, P. Ligand dependence of estrogen receptor induced changes in chromatin structure. Nucleic Acids Res. 20, 4525–4531 (1992).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  80. Henrikksson, A. et al. Role for the Ada adaptor complex in gene activation by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3065–3073 (1997).This paper shows that glucocorticoid-receptor-dependent activation requires the SAGA–ADA complex.

    Article  Google Scholar 

  81. Wallberg, A. E. et al. Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor τ1 activation domain. Mol. Cell. Biol. 20, 2004–2013 (2000).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  82. Anafi, M. et al. GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor. Mol. Endocrinol. 14, 718–732 (2000).

    Article  CAS  PubMed  Google Scholar 

  83. Vom Baur, E. et al. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors. Genes Dev. 12, 1278–1289 (1998).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  84. Bortvin, A. & Winston, F. Evidence that Spt6p controls chromatin structure by a direct interaction with histones. Science 272, 1473–1476 (1996).

    Article  CAS  PubMed  Google Scholar 

  85. Hartzog, G. A., Wada, T., Handa, H. & Winston, F. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev. 12, 357–369 (1998).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  86. Wada, T. et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12, 343–356 (1998).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  87. Baniahmad, C. et al. Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol. Endocrinol. 9, 34–43 (1995).

    CAS  PubMed  Google Scholar 

  88. Knutti, D., Kaul, A. & Kralli, A. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol. Cell. Biol. 20, 2411–2422 (2000).The authors carry out a screen, which identifies PGC-1 as a complementary DNA that potentiates glucocorticoid-receptor function in yeast.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  89. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829–839 (1998).

    Article  CAS  PubMed  Google Scholar 

  90. Puigserver, P. et al. Activation of PPARγ coactivator-1 through transcription factor docking. Science 286, 1368–1371 (1999).

    Article  CAS  PubMed  Google Scholar 

  91. Monsalve, M. et al. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol. Cell 6, 307–316 (2000).

    Article  CAS  PubMed  Google Scholar 

  92. Garabedian, M. J. & Yamamoto, K. R. Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Mol. Biol. Cell 3, 1245–1257 (1992).This report uses yeast to analyse the hormone-binding domain of the glucocorticoid receptor.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  93. Wrenn, C. K. & Katzenellenbogan, B. S. Structure–function analysis of the hormone binding domain of the estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J. Biol. Chem. 268, 24089–24098 (1993).

    CAS  PubMed  Google Scholar 

  94. Lind, U., Carlstedt-Duke, J., Gustafsson, J.-Å. & Wright A. P. H. Identification of single amino acid substitutions of Cys-736 that affect the steroid-binding affinity and specificity of the glucocorticoid receptor using phenotypic screening in yeast. Mol. Endocrinol. 10, 1358–1370 (1996).

    CAS  PubMed  Google Scholar 

  95. Kralli, A., Bohen, S. P. & Yamamoto, K. R. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natl Acad. Sci. USA 92, 4701–4705 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Gilbert, D. M., Heery, D. M., Losson, R., Chambon, P. & Lemoine, Y. Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1. Mol. Cell. Biol. 13, 462–472 (1993).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  97. Sitcheran, R., Emter, R., Kralli, A. & Yamamoto, K. R. A genetic analysis of glucocorticoid receptor signaling: identification and characterization of ligand-effect modulators in Saccharomyces cerevisiae. Genetics 156, 963–972 (2000).

    CAS  PubMed Central  PubMed  Google Scholar 

  98. Housley, P. R. & Pratt, W. B. Direct demonstration of glucocorticoid receptor phosphorylation by intact L-cells. J. Biol. Chem. 258, 4630–4635 (1983).

    CAS  PubMed  Google Scholar 

  99. Orti, E., Mendel, D. B., Smith, L. I. & Munck, A. Agonist dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells. J. Biol. Chem. 264, 9728–9731 (1989).

    CAS  PubMed  Google Scholar 

  100. Hoeck, W. & Groner, B. Hormone-dependent phosphorylation of the glucocorticoid receptor occurs mainly in the amino-terminal transactivation domain. J. Biol. Chem. 265, 5403–5408 (1990).

    CAS  PubMed  Google Scholar 

  101. Pocuca, N., Ruzdijic, S., Demonacos, C., Kanazir, D. & Krstic-Demonacos, M. Using yeast to study glucocorticoid receptor phosphorylation. J. Steroid Biochem. 66, 303–318 (1998).

    Article  CAS  Google Scholar 

  102. Krstic, M. D., Rogatsky, I., Yamamoto, K. R. & Garabedian, M. J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3947–3954 (1997).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  103. Epinat, J.-C., Whiteside, S. T., Rice, N. R. & Israel, A. Reconstitution of the NF-κ>B system in Saccharomyces cerevisiae for isolation of effectors by phenotype modulation. Yeast 13, 599–612 (1997).

    Article  CAS  PubMed  Google Scholar 

  104. Ayer, D. E., Kertzmer, L. & Eisenman, R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211–222 (1993).

    Article  CAS  PubMed  Google Scholar 

  105. Kasten, M. M., Ayer, D. E. & Stillman, D. J. SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein. Mol. Cell. Biol. 16, 4215–4221 (1996).This, to my knowledge, is the first report showing that mammalian repressors function in yeast.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  106. Ayer, D. E., Lawrence, Q. A. & Eisenman, R. N. Mad–Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767–776 (1995).

    Article  CAS  PubMed  Google Scholar 

  107. Weintraub, S. J., Prater, C. J. & Dean, D. C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358, 259–261 (1992).

    Article  CAS  PubMed  Google Scholar 

  108. Laherty, C. D. et al. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89, 349–356 (1997).

    Article  CAS  PubMed  Google Scholar 

  109. Kennedy, B. K. et al. Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proc. Natl Acad. Sci. USA 98, 8720–8725 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597–601 (1998).

    Article  CAS  PubMed  Google Scholar 

  111. Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473 (1998).

    Article  CAS  PubMed  Google Scholar 

  112. Magnaghi-Jaulin, L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601–605 (1998).

    Article  CAS  PubMed  Google Scholar 

  113. Chen, T.-T. & Wang, J. Y. J. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol. Cell. Biol. 20, 5571–5580 (2000).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  114. Dahiya, A., Gavin, M. R., Luo, R. X. & Dean, D. C. Role of the LXCXE binding site in Rb function. Mol. Cell. Biol. 20, 6799–6805 (2000).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  115. Dick, F. A., Sailhamer, E. & Dyson, N. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol. Cell. Biol. 20, 3715–3727 (2000).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgements

The author would like to thank A. Weiner for comments on the manuscript, and would also like to apologize for any reports that were not cited in the manuscript.

Author information

Authors and Affiliations

Authors

Related links

Related links

DATABASES

LocusLink:

FXR

 Saccharomyces Genome Database:

ADE2

ERG6

Gal4

Gcn4

His3

LEM1/PDR5

LEM3

PDR1

RPD3

SIN3

SNF12

Swi3

SWP73

 Swiss-Prot:

AP-1

c-Fos

c-Myb

c-Myc

glucocorticoid receptor

GRIP1

LacZ

MAD1

MAX

Oct1

p53

Pgc-1

PIG3

PPAR-γ

Sp1

v-Jun

v-Myb

Glossary

BASAL TRANSCRIPTION FACTORS

The minimal complement of proteins that is necessary to generate transcription from a minimal promoter.

HATs

Enzymes that have histone acetyltransferase activity. They are generally thought to stimulate transcription.

HDACs

Enzymes that deacetylate histones. They are generally thought to promote repressive chromatin states.

HISTONE METHYLASE

Enzyme that transfers methyl groups to histone tails.

HISTONE KINASE

Enzyme that phosphorylates histones.

TATA BOX

A DNA-binding site for the formation of transcription pre-initiation complexes that contain RNA polymerase.

ORTHOLOGUE

A pair of genes, one in each species, that are descended from a single gene. If these two genes encode proteins with functional similarity, they are referred to as functional orthologues.

ENHANCER ELEMENT

(Also known as upstream activating sequence (UAS) elements in yeast.) Upstream DNA-binding sequences for transcriptional activators.

HETEROLOGOUS

For this review, heterologous refers to mammalian proteins that are expressed in yeast, but do not have functional orthologues in yeast.

SECOND-SITE INTRAGENIC SUPPRESSOR

A second mutation in a gene that reverses the effect of the original mutation.

PHENOCOPY

An environmental or non-hereditary change that resembles the phenotype of a genetic mutation.

SWI/SNF

An ATP-dependent chromatin- modifying protein complex that is required for expression of many genes. This complex has also been implicated in transcriptional repression of other genes.

SAGA/ADA

A protein complex that includes Ada proteins, the TATA-binding protein (TBP) set of Spt gene products, and some TATA-box-associated factors (TAFs). This complex promotes transcriptional activation, at least in part, through histone acetyltransferase activity.

ATP-BINDING CASSETTE PROTEIN

From a large class of transport proteins that move molecules across membranes in an ATP-dependent manner.

DEXAMETHASONE

A potent glucocorticoid with immunosuppressant effects that potently stimulates the activity of some nuclear hormone receptors, including the glucocorticoid receptor.

NF-κB/IκB

NF-κB is a transcription factor that activates genes that are involved in cell growth, as well as immune and inflammatory responses. IκB is thought to interfere with NF-κB activity at least in part by sequestering it in the cytoplasm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kennedy, B. Mammalian transcription factors in yeast: strangers in a familiar land. Nat Rev Mol Cell Biol 3, 41–49 (2002). https://doi.org/10.1038/nrm704

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nrm704

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing